Antigen processing differences among APC

Human Immunology

Volumn 54, Issue 2, 1997, Pages 148-158

  Schneider, S C ^a,b   Sercarz, E E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KEYHOLE LIMPET HEMOCYANIN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; PROTEINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; DENDRITIC CELL; DISULFIDE BOND; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

ANTIGEN PRESENTATION; ANTIGENS; DENDRITIC CELLS; ENDOPEPTIDASES; EPITHELIAL CELLS; EPITHELIUM; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030842634     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00079-7     Document Type: Review

References (72)

1. Guery J-C, Adorini L: Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 154:536, 1995.
2. Matousek MP, Nedrud JG, Harding CV: Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J Immunol 156:4137, 1996.
3. Walker WS: Differential antigen presentation by cloned populations of mouse splenic macrophages. J Immunol 143:2142, 1989.
4. Trannoy E, Manser T, Cole MD, Daley MJ: Monoclonal c-myc transformed macrophage cell lines. J Immunol 151: 3042, 1993.
5. Michalek MT, Benacerraf B, Rock KL: Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing. Proc Natl Acad Sci USA 86:3316, 1989.
6. Vidard L, Rock KL, Benacerraf B: The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J Immunol 147:1786, 1991.
7. Vidard L, Rock KL, Benacerraf B: Heterogeneity in antigen processing by different types of antigen-presenting cells. J Immunol 149:1905, 1992.
8. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10, 1997.
9. Aiba S, Katz SI: The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent. J Immunol 146:2479, 1991.
10. De Bruijn ML, Nieland JD, Harding CV, Melief CJ: Processing and presentation of intact hen egg-white lysozyme by dendritic cells. Eur J Immunol 22:2347, 1992.
11. q antigen-presenting cells. Eur J Immunol 25:3235, 1995.
12. Michaelsson E, Holmdahl M, Engstrom A, Burkhardt H, Scheynius A, Holmdahl R: Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol 25:2234, 1995.
13. Lanzavecchia A: Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8:773, 1990.
14. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 181:1957, 1995.
15. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL: Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol 156:2809, 1996.
16. Demotz S, Grey HM, Appella E, Sette A: Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme. Nature 342:682, 1989.
17. Rudensky A, Preston-Hurlburt P, Hong S, Barlow A, Janeway CA: Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622, 1991.
18. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27, 1993.
19. Vignali DA, Urban RG, Chicz RM, Strominger JL: Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur J Immunol 23:1602, 1993.
20. Gammon G, Geysen HM, Apple RJ, Pickett E, Palmer M, Ametani A, Sercarz EE: T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J Exp Med 173: 609, 1991.
21. d-restricted hen egg lysozyme determinant 107-116. Eur J Immunol 26:1656, 1996.
22. k-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc Natl Acad Sci USA 92:2214, 1995.
23. Adorini L, Appella E, Doria G, Nagy ZA: Mechanisms influencing the immunodominance of T cell determinants. J Exp Med 168:2091, 1988.
24. Moudgil KD, Grewal IS, Jensen PE, Sercarz EE: Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J Exp Med 183:535, 1996.
25. Puri J, Factorovich Y: Selective inhibition of antigen presentation to cloned T cells by protease inhibitors. J Immunol 141:3313, 1988.
26. Takahashi H, Cease KB, Berzofsky JA: Identification of proteases that process distinct epitopes on the same protein. J Immunol 142:2221, 1989.
27. Diment S: Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J Immunol 145: 417, 1990.
28. Vidard L, Rock KL, Benacerraf B: Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J Immunol 149:498, 1992.
29. Van Noort JM, Jacobs MJM: Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules. Eur J Immunol 24:2175, 1994.
30. Mouritsen S, Meldal M, Werdelin O, Hansen AS, Buus S: MHC molecules protect T cell epitopes against proteolytic destruction. J Immunol 149:1987, 1992.
31. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenie determinants. Annu Rev Immunol 11:729, 1993.
32. Jensen PE: Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol 150:3347, 1993.
33. Lang Y, Forquet F, Speck E, Blum J, Delovitch TL: Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes 45:1711, 1996.
34. Nelson CA, Vidavsky I, Viner NJ, Gross ML, Unanue ER: Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 94:628, 1997.
35. Sette A, Adorini L, Colon SM, Buus S, Grey HM: Capacity of intact proteins to bind to MHC class II molecules. J Immunol 143:1265, 1989.
36. Sercarz EE, Wilbur S, Sadegh-Nasseri S, Miller A, Manca F, Gammon G, Shastri N: The molecular context of a determinant influences its dominant expression in a T cell response hierarchy through "fine-processing." Prog Immunol 6:227, 1986.
37. Allen PM, Unanue ER: Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol 132:1077, 1984.
38. Collins DS, Unanue ER, Harding CV: Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 147:4054, 1991.
39. Pisoni RL, Acker TL, Lisowski KM, Lemons RM, Thoene JG: A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis. J Cell Biol 110:327, 1990.
40. Pisoni RL, Thoene JG: The transport systems of mammalian lysosomes. Biochim Biophys Acta 1071:351, 1991.
41. Gainey D, Short S, McCoy KL: Intracellular location of cysteine transport activity correlates with productive processing of antigen disulfide. J Cell Phys 168:248, 1996.
42. Shen WC, Ryser HJ, LaManna L: Disulfide spacer between methotrexate and poly(D-lysine): a probe for exploring the reductive process in endocytosis. J Biol Chem 260:10905, 1985.
43. Feener EP, Shen WC, Ryser HJ: Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes. J Biol Chem 265:18780, 1990.
44. Bretscher MS, Lutter R: A new method for detecting endocytosed proteins. EMBO J 7:4087, 1988.
45. Mandel R, Ryser HJ, Niaki B, Ghani F, Shen WC: Isolation of variants of Chinese hamster ovary cells with abnormally low levels of GSH: decreased ability to cleave endocytosed disulfide bonds. J Cell Physiol 149:60, 1991.
46. Merkel BJ, Mandel R, Ryser HJ, McCoy KL: Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds. J Immunol 154:128, 1995.
47. Short S, Merkel BJ, Caffrey R, McCoy KL: Defective antigen processing correlates with a low level of intracellular gluthathione. Eur J Immunol 26:3015, 1996.
48. Frosch S, Bonifas U, Eck HP, Bockstette M, Droege W, Rüde E, Reske-Kunz AB: The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols. Eur J Immunol 23:1430, 1993.
49. Lechler R, Aichinger G, Lightstone L: The endogenous pathway of MHC class II antigen presentation. Immunol Rev 151:51, 1996.
50. Brooks W, Hartley S, Kjer-Nielsen L, Perera J, Goodnow CC, Basten A, McCluskey J: Class-II restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozome. Proc Natl Acad Sci USA 88:3290, 1991.
51. Calin-Laurens V, Forquet F, Mottez E, Kanellopoulos J, Godeau F, Kourilsky P, Gerlier D, Rabourdin-Combe C: Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol 21:761, 1991.
52. Calin-Laurens V, Forquet F, Lombard-Platet S, Bertolino P, Chrétien I, Trescol-Biémont M-C, Gerlier D, Rabourdin-Combe C: High efficiency of endogenous antigen presentation by MHC class II molecules. Int Immunol 4:1113, 1992.
53. Brooks AG, McCluskey J: Class II-restricted presentation of a hen egg lysozome determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J Immunol 150:3690, 1993.
54. Pelham HR: The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem Sci 15:483, 1990.
55. Humbert M, Bertolino P, Forquet F, Rabourdin-Combe C, Gerlier D, Davoust J, Salamero J: Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chain and is sensitive to lysosomotropic agents. Eur J Immunol 23:3167, 1993.
56. Adorini L, Guery J-C, Fuchs S, Ortiz-Navarrete V, Hämmerling GJ, Momburg F: Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells. J Immunol 151:3576, 1993.
57. 2-microglobulin to class II-restricted T cells leads to self-tolerance. J Immunol 154: 545, 1995.
58. Sprent J, Lo D, Gao E, Ron Y: T cell selection in the thymus. Immunol Rev 101:173, 1988.
59. Hogquist KA, Bevan MJ: The nature of the peptide/MHC ligand involved in positive selection. Semin Immunol 8:63, 1996.
60. Marrack P, Kappler J: The T cell receptor. Science 238: 1073, 1987.
61. Kourilsky P, Claverie JM: MHC restriction, alloreactivity and thymic education: a common link. Cell 56:327, 1989.
62. Marrack P, McCormack J, Kappler J: Presentation of antigen, foreign major histocompatibility complex proteins and self by thymus cortical epithelium. Nature 338:503, 1989.
63. Marrack P, Ignatowicz L, Kappler J, Boymel J, Freed JH: Comparison of peptides bound to spleen and thymus class II. J Exp Med 178:2173, 1993.
64. Lorenz RG, Allen PM: Thymic cortical epithelial cells can present self-antigens in vivo. Nature 337:560, 1989.
65. Lorenz RG, Allen PM: Thymic cortical epithelial cells lack full capacity for antigen presentation. Nature 340: 557, 1989.
66. Ransom J, Wu R, Fischer M, Zlotnik A: Antigen presenting ability of thymic macrophages and epithelial cells: evidence for defects in the antigen processing function of thymic epithelial cells. Cell Immunol 134:180, 1991.
67. Mizuochi T, Michiyuki K, Kokuho T, Kakiuchi T, Hirokawa K: Medullary but cortical thymic epithelial cells present soluble antigens to helper T cells. J Exp Med 175:1601, 1992.
68. Kasai M, Hirokawa K, Kajino K, Ogasawara K, Tatsumi M, Hermel E, Monaco JJ, Mizochi T: Difference in antigen presentation pathways between cortical and medullary thymic epithelial cells. Eur J Immunol 26:2101, 1996.
69. Murphy DB, Lo D, Rath S, Brinster RL, Flavell RA, Slanetz A, Janeway CA: A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature 338: 765, 1989.
70. b complex by isolated thymic stromal cells. Int Immunol 12, 1994.
71. Farr A, DeRoos PC, Eastman S, Rudensky AY: Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells. Eur J Immunol 26:3185, 1996.
72. Oukka M, Colucci-Guyon E, Tran PL, Cohen-Tannoudji M, Babinet C, Lotteau V, Kosmatopoulos K: CD4 cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 4:545, 1996.